ADAGE CAPITAL PARTNERS GP, L.L.C. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2021$10,608,000
+50.3%
200,000
+100.0%
0.02%
+35.7%
Q3 2021$7,059,000
-71.7%
100,000
-60.0%
0.01%
-81.1%
Q1 2020$24,915,000250,0000.07%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders